These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35881223)

  • 1. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
    Jiang C; Wang Y; Zhang M; Xu J
    Mol Biol Rep; 2022 Oct; 49(10):9217-9229. PubMed ID: 35881223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling.
    Lu J; Shi X; Fu Q; Han Y; Zhu L; Zhou Z; Li Y; Lu N
    Cell Mol Biol Lett; 2024 Jul; 29(1):100. PubMed ID: 38977961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
    Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
    J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
    Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
    Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Effect of LGS and ODE Isolated from the Twigs of
    Kim GR; Kim EN; Park KJ; Kim KH; Jeong GS
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33810014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
    Gong W; Liu M; Zhang Q; Zhang Q; Wang Y; Zhao Q; Xiang L; Zheng C; Zhang Q; Qin L
    Oxid Med Cell Longev; 2022; 2022():5410377. PubMed ID: 35585885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed electromagnetic fields inhibit osteoclast differentiation in RAW264.7 macrophages via suppression of the protein kinase B/mammalian target of rapamycin signaling pathway.
    Lei Y; Su J; Xu H; Yu Q; Zhao M; Tian J
    Mol Med Rep; 2018 Jul; 18(1):447-454. PubMed ID: 29749519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids Enhanced Osteoclast Autophagy Through the PI3K/Akt/mTOR Signaling Pathway.
    Fu L; Wu W; Sun X; Zhang P
    Calcif Tissue Int; 2020 Jul; 107(1):60-71. PubMed ID: 32274533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
    Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
    Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulphide promotes osteoclastogenesis by inhibiting autophagy through the PI3K/AKT/mTOR pathway.
    Ma J; Du D; Liu J; Guo L; Li Y; Chen A; Ye T
    J Drug Target; 2020 Feb; 28(2):176-185. PubMed ID: 31134826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 prevents RANKL-induced osteoclastogenesis by promoting autophagy via inactivation of the PI3K/AKT/mTOR and MAPK pathways.
    Zheng D; Cui C; Ye C; Shao C; Zha X; Xu Y; Liu X; Wang C
    Braz J Med Biol Res; 2024; 57():e13474. PubMed ID: 38716985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways.
    Jin X; Li Y; Yang Y; Shen H; Chen J; Xu B; Xu J
    J Orthop Surg Res; 2022 Jan; 17(1):53. PubMed ID: 35093114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway.
    Wang N; Hao Y; Fu L
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orcinol gentiobioside inhibits RANKL-induced osteoclastogenesis by promoting apoptosis and suppressing autophagy via the JNK1 signaling.
    Lian C; Gong W; Zhao X; Sun P; Hu S; Zhou G; Zhang Q; Qin L
    J Ethnopharmacol; 2024 Jun; 328():118060. PubMed ID: 38521429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells.
    Wang S; Liu Z; Wang J; Ji X; Yao Z; Wang X
    Mol Med Rep; 2020 Mar; 21(3):1125-1132. PubMed ID: 32016444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS Promote Ox-LDL-Induced Platelet Activation by Up-Regulating Autophagy Through the Inhibition of the PI3K/AKT/mTOR Pathway.
    Wang X; Fu YF; Liu X; Feng G; Xiong D; Mu GF; Chen FP
    Cell Physiol Biochem; 2018; 50(5):1779-1793. PubMed ID: 30384368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.